2ndVote Life Neutral Plus ETF

2ndVote Life Neutral Plus ETF

LYFE

$33.58

Updated: 23/09/2026, 01:40:47

Market Cap
$6.69B
Sector
Financial Services
Industry
Asset Management
Country
US

No historical data available

Company Profile

This actively managed exchange-traded fund (ETF) primarily invests its capital, potentially including borrowed funds for investment, in the equity securities of large and mid-capitalization companies. These companies are either based in the U.S. or have their shares principally traded on U.S. securities markets. A key component of its strategy is that these companies must align with the fund's specific pro-life social criteria. The selection of these stocks is carried out through a combination of fundamental security analysis and the application of its own proprietary social scoring system.

USD
CBOE
Asset Summaries
Latest generated summaries for LYFE

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for LYFE.
Share price
$33.58
Market cap
$6.69B
Exchange
CBOE
Currency
USD
CEO
N/A
Employees
N/A
IPO date
17/11/2020
Beta
0
Last dividend
$0.00
Day range
$33.58 – $33.64
52-week range
$28.84 – $34.38
1-day performance
-0.09%
1-year performance
16.45%
Current drawdown (1Y)
-2.31%
CIK
0001811168
CUSIP
81386P108
ISIN
US81386P1084
Created
07/12/2025, 05:08:34
Last update
23/09/2026, 01:40:47

Track 2ndVote Life Neutral Plus ETF with an AI analyst

See which prediction-market events move LYFE, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to LYFE from your Railway `news_articles` table.

No news found for this symbol.